{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:31:16Z","timestamp":1786984276892,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.ahj.2004.03.067","type":"journal-article","created":{"date-parts":[[2005,3,5]],"date-time":"2005-03-05T07:11:39Z","timestamp":1110006699000},"page":"329-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Fluvastatin reduces the impact of diabetes on long-term outcome after coronary intervention\u2014A Lescol Intervention Prevention Study (LIPS) substudy"],"prefix":"10.1016","volume":"149","author":[{"given":"Chourmouzios A.","family":"Arampatzis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick","family":"Goedhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Serruys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Saia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro A.","family":"Lemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim","family":"de Feyter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2004.03.067_bib1","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0095-4543(05)70133-0","article-title":"Hyperglycemia as a risk factor for cardiovascular disease in type 2 diabetes","volume":"26","author":"Laakso","year":"1999","journal-title":"Prim. Care"},{"key":"10.1016\/j.ahj.2004.03.067_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahj.2004.03.067_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-133-2-200007180-00007","article-title":"Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"133","author":"Saito","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ahj.2004.03.067_bib4","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0735-1097(98)00467-7","article-title":"Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement","volume":"32","author":"Elezi","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahj.2004.03.067_bib5","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/01.CIR.91.4.979","article-title":"Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty","volume":"91","author":"Stein","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.03.067_bib6","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/01.CIR.96.6.1761","article-title":"Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI)","volume":"96","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.03.067_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/hc3101.093700","article-title":"Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial","volume":"104","author":"Abizaid","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.03.067_bib8","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group","volume":"339","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahj.2004.03.067_bib9","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2004.03.067_bib10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahj.2004.03.067_bib11","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahj.2004.03.067_bib12","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2004.03.067_bib13","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1001\/jama.287.24.3215","article-title":"Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial","volume":"287","author":"Serruys","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2004.03.067_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/14628840127765","article-title":"The Lescol(R) Intervention Prevention Study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease","volume":"4","author":"Serruys","year":"2001","journal-title":"Int. J. Cardiovasc. Intervent."},{"key":"10.1016\/j.ahj.2004.03.067_bib15","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1161\/01.CIR.102.16.1893","article-title":"Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project","volume":"102","author":"Sacks","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.03.067_bib16","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/01.CIR.94.8.1818","article-title":"Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry","volume":"94","author":"Kip","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.03.067_bib17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7326\/0003-4819-118-5-199303010-00004","article-title":"Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus","volume":"118","author":"Carrozza","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ahj.2004.03.067_bib18","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/01.CIR.95.6.1366","article-title":"Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study","volume":"95","author":"Kornowski","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.03.067_bib19","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0735-1097(99)00338-1","article-title":"Tissue characteristics of restenosis after percutaneous transluminal coronary angioplasty in diabetic patients","volume":"34","author":"Moreno","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahj.2004.03.067_bib20","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJM199006213222503","article-title":"Thromboxane biosynthesis and platelet function in type II diabetes mellitus","volume":"322","author":"Davi","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahj.2004.03.067_bib21","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0735-1097(02)01971-X","article-title":"Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients","volume":"40","author":"Van Belle","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahj.2004.03.067_bib22","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(99)10018-7","article-title":"Outcomes at 1 year and economic implications of platelet glycoprotein IIb\/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of platelet IIb\/IIIa inhibitor for stenting","volume":"354","author":"Topol","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2004.03.067_bib23","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0735-1097(02)01891-0","article-title":"The effect of intracoronary radiation for the treatment of recurrent in-stent restenosis in patients with diabetes mellitus","volume":"39","author":"Gruberg","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahj.2004.03.067_bib24","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/0735-1097(95)00496-3","article-title":"Potential mechanisms promoting restenosis in diabetic patients","volume":"27","author":"Aronson","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahj.2004.03.067_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2362.1994.tb02179.x","article-title":"Enhanced arterial intimal thickening after balloon catheter injury in diabetic animals accompanied by PDGF \u03b2-receptor overexpression of aortic media","volume":"24","author":"Kanzaki","year":"1994","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ahj.2004.03.067_bib26","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1172\/JCI117081","article-title":"Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation","volume":"93","author":"Bornfeldt","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ahj.2004.03.067_bib27","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1001\/archinte.159.22.2661","article-title":"Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study","volume":"159","author":"Haffner","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ahj.2004.03.067_bib28","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0735-1097(97)00259-3","article-title":"Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of restenosis by elisor after transluminal coronary angioplasty","volume":"30","author":"Bertrand","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahj.2004.03.067_bib29","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJM199411173312002","article-title":"Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group","volume":"331","author":"Weintraub","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahj.2004.03.067_bib30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/euhj.1998.1150","article-title":"A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial","volume":"20","author":"Serruys","year":"1999","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ahj.2004.03.067_bib31","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM199502233320802","article-title":"The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion","volume":"332","author":"Anderson","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahj.2004.03.067_bib32","doi-asserted-by":"crossref","first-page":"122A","DOI":"10.1016\/S0002-9149(05)80033-5","article-title":"Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease","volume":"76","author":"Eichstadt","year":"1995","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ahj.2004.03.067_bib33","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0735-1097(99)00018-2","article-title":"Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile","volume":"33","author":"Dangas","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahj.2004.03.067_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.CIR.101.2.207","article-title":"Current perspectives on statins","volume":"101","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.03.067_bib35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/107424840000500304","article-title":"Fluvastatin: effects beyond cholesterol lowering","volume":"5","author":"Corsini","year":"2000","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.ahj.2004.03.067_bib36","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/01.CIR.0000034447.02535.D5","article-title":"Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up","volume":"106","author":"Degertekin","year":"2002","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870304005344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870304005344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:12:38Z","timestamp":1757567558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870304005344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0002870304005344"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2004.03.067","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluvastatin reduces the impact of diabetes on long-term outcome after coronary intervention\u2014A Lescol Intervention Prevention Study (LIPS) substudy","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2004.03.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}